[CCR4 as a molecular target for novel immunotherapy in malignant lymphoma].
Ishida
Takashi
T
D000818:Animals; D000906:Antibodies / Q000627:therapeutic use; D000920:Antibody-Dependent Cell Cytotoxicity; D015704:CD4 Antigens; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D053645:Interleukin-2 Receptor alpha Subunit; D008223:Lymphoma / Q000276:immunology / Q000628:therapy*; D054398:Receptors, CCR4; D019707:Receptors, Chemokine / Q000276:immunology / Q000502:physiology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D000906:Antibodies; C515354:CCR4 protein, human; D015704:CD4 Antigens; D053645:Interleukin-2 Receptor alpha Subunit; D054398:Receptors, CCR4; D019707:Receptors, Chemokine